fbpx

Student Research
Papers

GENE 225:
Healthcare
Venture Capital

Instructors for this course:

Michael Snyder, PhD
Stanford W. Ascherman, MD, FACS, Professor in Genetics

Ronjon Nag, PhD
Interdisciplinary Stanford Distinguished Careers Institute Fellow
Director, R42 Longevity Fund

Anastasiya Giarletta
Principal, R42 Fund
Gene 225 Teaching Assistant

 

  • How are healthcare startups financed? Venture funds invest in risky companies but how do they themselves get funded, and how do they evaluate companies? How do company founders prepare for capital raising?
  • How does intellectual property play? We explain both from the investor and founder viewpoints to analyze how to a) start a venture capital fund; b) present a healthcare company to a venture fund.
  • We discuss financial frameworks specifically for the healthcare sector and how it differs to other segments. Additionally, guest lectures from venture capitalists, angel investors, and company founders will explain their respective perspectives.

 

Empatica E4 Wristband

Infectious Disease and COVID-19
 Wearables Study

Can wearables help detect Infectious Disease or COVID-19 before symptoms emerge? Learn More >

Spring 2021 Papers

J.A.
Investing in Global Health Innovations: A Decision-Making Framework
Paper

Andrew Barnett
Applying Precision Medicine to Long-Term Care Insurance
Paper     Slidedeck

Kate Buellesbach
It’s a Woman’s World: Femtech for the 21st Century
Paper

Kellyann Burlage
Venture Opportunities in Women’s Health: Closing the Gender Health Gap
Paper     Slidedeck

Cam Burton
Shifting Incentives: Exploring the future of Personalized medicine In the biotechnology industry
Paper    

Pam Cai
Comparison of the investment size and returns in tech vs. biotech companies
Paper     Slidedeck

Skyler Castillo-Wilson
Alternative Advanced Degree Funding Model for Accelerated Research and Discounted Equity Rates
Paper

Ben Conrad
Medicare Advantage: Understanding the Program & Two New Innovative Upstarts
Paper    

Caroline Dunn
RETHINKING THE MENTAL HEALTH PSYCHIATRY MODEL WITH TELEMEDICINE
Paper     Slidedeck

Jacob Edelson
CRISPR Start-ups that Pivoted to COVID-19 Testing
Paper 

Areian Eghball
Mental Health Thesis
Making sense of a crowded space
Paper     Slidedeck

Ahmed Elbakri
Regulatory Planning and Budgeting for the Commercialization of AI-Enabled Rapid Diagnostics Platforms-
A Guide for Diagnostics Entrepreneurs
Paper

Christopher Fisher
-Medical Device Innovations-
A review of founder and investor perspectives
Paper 

Grace Catherine Benoist Fish
2021 Venture Capital Opportunities in the Mental Healthcare Space
Paper    

Nicolas Garcia
Funding The “Full-Stack” Doctor – The role VC can play in the Healthcare of the Future
Paper     Slidedeck

Betty Ha
2020s The Age of Biotech
Paper    


Stephanie Huang

The Roaring 20’s as the decade of biotech
Paper

Sanjay Iyer
The Role of Artificial Intelligence in Digital Health
Paper

Kathy Ku
Recents Trends in Women’s Health Consumer Brands
Paper

Esmond Lee
How universities can Bridge the Biotech Valley of Death for Cell & Gene Therapies
Paper

PJ Loury
Liquid Biopsy: Integral to the next generation of cancer treatment?
Paper

Ricardo Jacob Mack
The Relationship of Healthcare Affordability and Biotech Industry
Paper

Angel Madero
Healthcare and Biotech in Latin America:
Paper

Ben Marafino
Growing diseconomies of scale in pharmaceutical R&D productivity and
manufacture will likely compound “payer-reluctance risk” for novel therapeutics
Paper

Vincent Masto
SPACs in biotech are here to stay
Paper   Slidedeck

Samson Joel Mataraso
Incentivizing Investment in Antibiotic Development to Tackle Rising
Antibiotic Resistance
Paper

Yanick Mulumba
The role of patents in valuation of biotech companies: A case study
Paper 

Floriane Ngako Kameni
Investing in Health Equity
Paper

Brandon Nydick
Evaluating Medical Device Startups: A Quantitative Framework for Venture Capitalists
Paper

Pettie Kade Ploussard
ML-guided biomolecule evolution companies are more numerous than they appear
Paper

Megan Roche, MD
Women in Venture Capital: How Underrepresentation Impacts Business And Society
Powerpoint
Paper     Slidedeck

Sarah Runkle
“We’re Not a Vitamin Company, We’re a Tech Company”
A memo for investors considering the supplements space
Paper 

Jarod Rutledge
An Investment Assessment of Emerging Science in Longevity Biotechnology
Paper 

Donya Sarrafian
IP Protection & the Case for 100 Year Patents
Powerpoint
Paper     Slidedeck

A.I.S.
Value-Based Pharmaceutical Pricing:
A Framework for Addressing High Drug Costs
Paper     Slidedeck

Youngyoon Amy Seo
Incyte Corporation:
A venture capitalist’s dream
Paper     Slidedeck

Shannon Kayj
Creating Biological Systems Overview
Paper     Slidedeck

Diva Sharma
Healthcare Financing Companies Need A More Contrarian Approach to Scale Quicker
Paper     Slidedeck

M. T.
Optimizing the Clinical Trial
Paper 

Joan E. Thompson
Gender Imbalance in Healthcare Venture Capitol:
Reviewing Market Perspectives on Arbitage & Parity
Paper     Slidedeck

Zach Walters
Precision Medicine and Mental health
Paper     Slidedeck

Victor Yin
Hong Kong Biotech IPOs
Paper    

Yihui Zhang
Funding for Cure: A Scoring Framework to Invest the Best Science
Paper    

 

 

css.php
Share This